Literature DB >> 1729179

T-cell immune responses in Mycobacterium avium-infected mice.

R D Hubbard1, C M Flory, F M Collins.   

Abstract

Mycobacterium avium infection was substantially more severe in C57BL/6 (Bcgs) than in (C57BL/6 x DBA/2)F1 hybrid (Bcgr) mice both in terms of bacterial growth in the spleens and lungs and in host survival. Prior Mycobacterium bovis BCG vaccination resulted in increased resistance as well as enhanced tuberculin hypersensitivity to both PPD-S (Mycobacterium tuberculosis) and PPD-A (M. avium). Mice heavily infected with M. avium were used as T-cell donors in an adoptive transfer system. Substantial resistance was observed for both recipient hosts regardless of the genotype of the donor strain. Transfer of resistance was ablated by treatment of the immune spleen cells with anti-Thy 1.2 monoclonal antibody and complement or by cyclophosphamide treatment. Spleen cells which were monodepleted of L3T4+ or Lyt-2+ T cells did not lose their ability to transfer resistance against a subsequent challenge. However, when these cells were doubly deleted, all resistance was ablated in both the BCG-susceptible and -resistant mice. The recipient host expressed a detectable adoptive immune response although the donor had been unable to reduce the growth of the primary M. avium infection in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729179      PMCID: PMC257515          DOI: 10.1128/iai.60.1.150-153.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice.

Authors:  R W Stokes; F M Collins
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

Review 2.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

3.  Mycobacteria and AIDS mortality.

Authors:  R E Chaisson; P C Hopewell
Journal:  Am Rev Respir Dis       Date:  1989-01

4.  Role of mononuclear phagocytes in expression of resistance and susceptibility to Mycobacterium avium infections in mice.

Authors:  R W Stokes; I M Orme; F M Collins
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

5.  Genetic control of resistance to Mycobacterium intracellulare infection in mice.

Authors:  Y Goto; R M Nakamura; H Takahashi; T Tokunaga
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

6.  Childhood tuberculosis in Sweden. An epidemiological study made six years after the cessation of general BCG vaccination of the newborn.

Authors:  V Romanus
Journal:  Tubercle       Date:  1983-06

7.  Delayed hypersensitivity responses in mice and guinea pigs to Mycobacterium leprae, Mycobacterium vaccae, and Mycobacterium nonchromogenicum cytoplasmic proteins.

Authors:  S R Watson; N E Morrison; F M Collins
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

8.  Immune response to persistent mycobacterial infection in mice.

Authors:  F M Collins; N E Morrison; V Montalbine
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

Review 9.  Antituberculous immunity: new solutions to an old problem.

Authors:  F M Collins
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct

10.  Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients.

Authors:  I M Orme; F M Collins
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  14 in total

1.  Interaction of Mycobacterium avium with human monocyte-derived dendritic cells.

Authors:  N Mohagheghpour; A van Vollenhoven; J Goodman; L E Bermudez
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 2.  Immunobiology of Mycobacterium avium infection.

Authors:  L E Bermudez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

3.  Identification of epitopes of fibronectin attachment protein (FAP-A) of Mycobacterium avium which stimulate strong T-cell responses in mice.

Authors:  M A Holsti; J S Schorey; E J Brown; P M Allen
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Processing and presentation of an antigen of Mycobacterium avium require access to an acidified compartment with active proteases.

Authors:  M A Holsti; P M Allen
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis.

Authors:  A A Chackerian; T V Perera; S M Behar
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells.

Authors:  E Martin; A T Kamath; J A Triccas; W J Britton
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium.

Authors:  A Sarmento; R Appelberg
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

8.  Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice.

Authors:  A S Apt; V G Avdienko; B V Nikonenko; I B Kramnik; A M Moroz; E Skamene
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

Review 9.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Immune responsiveness in Mycobacterium avium-infected mice: changes in the proportion of T cell subsets and antibody production during the course of infection.

Authors:  D L Xu; Y Goto; K K Amoako; T Nagatomo; K Uchida; T Shinjo
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.